CYTODYN ACQUIRES ADVANCED INFLUENZA TECHNOLOGIES, INC. FROM UTEK CORPORATION

CytoDyn, Inc., a development stage biotechnology company, and UTEK Corporation, a specialty finance company focused on technology transfer, announced that CytoDyn has acquired Advanced Influenza Technologies, Inc. (AIT), a wholly owned subsidiary of UTEK, in a stock transaction. AIT holds the license for a DNA-based Influenza vaccine candidate developed at the University of Massachusetts Medical School in Worcester, MA. Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=3487046)